NANCY JANE BOLLINGER
Physical Therapy in Indianapolis, IN
License number
Pennsylvania PT009586L
Category
Physical Therapy
Type
Physical Therapist
Address
Address
2
Indianapolis, IN 46268
Pennsylvania
Pennsylvania
Professional information
Nancy J Bollinger, Indianapolis IN - PT (Physical therapy)
Specialties:
Physical Therapy
Address:
10340 Splendor Way, Indianapolis 46234
(317) 852-1869 (Phone)
(317) 852-1869 (Phone)
Languages:
English
Method Of Treating Endotoxic Shock In Mammals
US Patent:
5294613, Mar 15, 1994
Filed:
Feb 7, 1992
Appl. No.:
7/834181
Inventors:
Nancy G. Bollinger - Indianapolis IN
Theodore Goodson - Indianapolis IN
David K. Herron - Indianapolis IN
Theodore Goodson - Indianapolis IN
David K. Herron - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3141
US Classification:
514242
Abstract:
This invention provides benzene derivatives, pharmaceutical formulations of those derivatives, and a method of using the derivatives for the treatment of inflammation in mammals.
Anti-Inflammatory Agents
US Patent:
4945099, Jul 31, 1990
Filed:
Jun 5, 1989
Appl. No.:
7/361873
Inventors:
Nancy G. Bollinger - Indianapolis IN
Theodore Goodson - Indianapolis IN
David K. Herron - Indianapolis IN
Theodore Goodson - Indianapolis IN
David K. Herron - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D25704, A61K 3141, A61K 31275, C07C 4984
US Classification:
514381
Abstract:
This invention provides benzene derivatives, pharmaceutical formulations of those derivatives, and a method of using the derivatives for the treatment of inflammation in mammals.
Anti-Inflammatory Agents
US Patent:
5098613, Mar 24, 1992
Filed:
Jul 11, 1990
Appl. No.:
7/551221
Inventors:
Nancy G. Bollinger - Indianapolis IN
Theodore Goodson - Indianapolis IN
David K. Herron - Indianapolis IN
Theodore Goodson - Indianapolis IN
David K. Herron - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C11C 100, A61K 3141
US Classification:
260413
Abstract:
This invention provides benzene derivatives, pharmaceutical formulations of those derivatives, and a method of using the derivatives for the treatment of inflammation in mammals.